Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression

Gregory Lizée, Joeri L. Aerts, Monica I. Gonzales, Nachimuthu Chinnasamy, Richard A. Morgan, Suzanne Topalian

Research output: Contribution to journalArticle

Abstract

The use of lentiviral vectors for basic research and potential future clinical applications requires methodologies that can accurately determine lentiviral titers and monitor viral transgene expression within target cells, beyond the context of reporter genes typically used for this purpose. Here we describe a quantitative RT-PCR (qRT-PCR) method that achieves both goals using primer sequences that are specific for the woodchuck hepatitis virus posttranscriptional regulatory element (WPRE), an enhancer contained in many retroviral vectors and that is incorporated in the 3′ UTR of nascent transgene transcripts. Quantitation of titers of three recombinant lentiviruses, genetically identical except for the transgene, demonstrated consistent differences in titer that were likely due to transgene-associated toxicity in producer cells and target cells. Viruses encoding the tumor-associated antigens tyrosinase and neo-poly(A) polymerase yielded reproducibly lower titers than a virus encoding enhanced green fluorescent protein (GFP) at the viral RNA, integrated DNA, and transgene mRNA levels, as measured by WPRE qPCR. Furthermore, the magnitude of differences in expression of the three transgenes in transduced target cells could not have been predicted by measuring vector DNA integration events. Since transgene expression in target cells is the most common goal of lentiviral transduction, and since methods to quantify transgene expression on the protein level are not always readily available, qRT-PCR based on a nucleotide sequence included in the transcript provides a useful tool for titering novel recombinant lentiviruses.

Original languageEnglish (US)
Pages (from-to)497-507
Number of pages11
JournalHuman Gene Therapy
Volume14
Issue number6
DOIs
StatePublished - Apr 10 2003
Externally publishedYes

Fingerprint

Reverse Transcriptase Polymerase Chain Reaction
Transgenes
Woodchuck Hepatitis B Virus
Lentivirus
Polynucleotide Adenylyltransferase
Polymerase Chain Reaction
Monophenol Monooxygenase
DNA
Viral RNA
3' Untranslated Regions
Neoplasm Antigens
Viral Load
Reporter Genes
Viruses
Messenger RNA
Research
Proteins

ASJC Scopus subject areas

  • Genetics

Cite this

Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. / Lizée, Gregory; Aerts, Joeri L.; Gonzales, Monica I.; Chinnasamy, Nachimuthu; Morgan, Richard A.; Topalian, Suzanne.

In: Human Gene Therapy, Vol. 14, No. 6, 10.04.2003, p. 497-507.

Research output: Contribution to journalArticle

Lizée, Gregory ; Aerts, Joeri L. ; Gonzales, Monica I. ; Chinnasamy, Nachimuthu ; Morgan, Richard A. ; Topalian, Suzanne. / Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. In: Human Gene Therapy. 2003 ; Vol. 14, No. 6. pp. 497-507.
@article{f7f28a4d5a684e53a11bfe68df39136b,
title = "Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression",
abstract = "The use of lentiviral vectors for basic research and potential future clinical applications requires methodologies that can accurately determine lentiviral titers and monitor viral transgene expression within target cells, beyond the context of reporter genes typically used for this purpose. Here we describe a quantitative RT-PCR (qRT-PCR) method that achieves both goals using primer sequences that are specific for the woodchuck hepatitis virus posttranscriptional regulatory element (WPRE), an enhancer contained in many retroviral vectors and that is incorporated in the 3′ UTR of nascent transgene transcripts. Quantitation of titers of three recombinant lentiviruses, genetically identical except for the transgene, demonstrated consistent differences in titer that were likely due to transgene-associated toxicity in producer cells and target cells. Viruses encoding the tumor-associated antigens tyrosinase and neo-poly(A) polymerase yielded reproducibly lower titers than a virus encoding enhanced green fluorescent protein (GFP) at the viral RNA, integrated DNA, and transgene mRNA levels, as measured by WPRE qPCR. Furthermore, the magnitude of differences in expression of the three transgenes in transduced target cells could not have been predicted by measuring vector DNA integration events. Since transgene expression in target cells is the most common goal of lentiviral transduction, and since methods to quantify transgene expression on the protein level are not always readily available, qRT-PCR based on a nucleotide sequence included in the transcript provides a useful tool for titering novel recombinant lentiviruses.",
author = "Gregory Liz{\'e}e and Aerts, {Joeri L.} and Gonzales, {Monica I.} and Nachimuthu Chinnasamy and Morgan, {Richard A.} and Suzanne Topalian",
year = "2003",
month = "4",
day = "10",
doi = "10.1089/104303403764539387",
language = "English (US)",
volume = "14",
pages = "497--507",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression

AU - Lizée, Gregory

AU - Aerts, Joeri L.

AU - Gonzales, Monica I.

AU - Chinnasamy, Nachimuthu

AU - Morgan, Richard A.

AU - Topalian, Suzanne

PY - 2003/4/10

Y1 - 2003/4/10

N2 - The use of lentiviral vectors for basic research and potential future clinical applications requires methodologies that can accurately determine lentiviral titers and monitor viral transgene expression within target cells, beyond the context of reporter genes typically used for this purpose. Here we describe a quantitative RT-PCR (qRT-PCR) method that achieves both goals using primer sequences that are specific for the woodchuck hepatitis virus posttranscriptional regulatory element (WPRE), an enhancer contained in many retroviral vectors and that is incorporated in the 3′ UTR of nascent transgene transcripts. Quantitation of titers of three recombinant lentiviruses, genetically identical except for the transgene, demonstrated consistent differences in titer that were likely due to transgene-associated toxicity in producer cells and target cells. Viruses encoding the tumor-associated antigens tyrosinase and neo-poly(A) polymerase yielded reproducibly lower titers than a virus encoding enhanced green fluorescent protein (GFP) at the viral RNA, integrated DNA, and transgene mRNA levels, as measured by WPRE qPCR. Furthermore, the magnitude of differences in expression of the three transgenes in transduced target cells could not have been predicted by measuring vector DNA integration events. Since transgene expression in target cells is the most common goal of lentiviral transduction, and since methods to quantify transgene expression on the protein level are not always readily available, qRT-PCR based on a nucleotide sequence included in the transcript provides a useful tool for titering novel recombinant lentiviruses.

AB - The use of lentiviral vectors for basic research and potential future clinical applications requires methodologies that can accurately determine lentiviral titers and monitor viral transgene expression within target cells, beyond the context of reporter genes typically used for this purpose. Here we describe a quantitative RT-PCR (qRT-PCR) method that achieves both goals using primer sequences that are specific for the woodchuck hepatitis virus posttranscriptional regulatory element (WPRE), an enhancer contained in many retroviral vectors and that is incorporated in the 3′ UTR of nascent transgene transcripts. Quantitation of titers of three recombinant lentiviruses, genetically identical except for the transgene, demonstrated consistent differences in titer that were likely due to transgene-associated toxicity in producer cells and target cells. Viruses encoding the tumor-associated antigens tyrosinase and neo-poly(A) polymerase yielded reproducibly lower titers than a virus encoding enhanced green fluorescent protein (GFP) at the viral RNA, integrated DNA, and transgene mRNA levels, as measured by WPRE qPCR. Furthermore, the magnitude of differences in expression of the three transgenes in transduced target cells could not have been predicted by measuring vector DNA integration events. Since transgene expression in target cells is the most common goal of lentiviral transduction, and since methods to quantify transgene expression on the protein level are not always readily available, qRT-PCR based on a nucleotide sequence included in the transcript provides a useful tool for titering novel recombinant lentiviruses.

UR - http://www.scopus.com/inward/record.url?scp=0037431266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037431266&partnerID=8YFLogxK

U2 - 10.1089/104303403764539387

DO - 10.1089/104303403764539387

M3 - Article

C2 - 12718761

AN - SCOPUS:0037431266

VL - 14

SP - 497

EP - 507

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 6

ER -